Rackoff WR - Search Results

1

Predicting the risk of bacteremia in childen with fever and neutropenia.

Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Rackoff WR, et al. J Clin Oncol. 1996 Mar;14(3):919-24. doi: 10.1200/JCO.1996.14.3.919. J Clin Oncol. 1996. PMID: 8622040

2

Risk factors in children with fever and neutropenia.

Rackoff W, Breitfeld P. Rackoff W, et al. J Clin Oncol. 2001 Nov 15;19(22):4270-1. doi: 10.1200/JCO.2001.19.22.4270. J Clin Oncol. 2001. PMID: 11709573 No abstract available.

3

High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors.

Kreissman SG, Rackoff W, Lee M, Breitfeld PP. Kreissman SG, et al. J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):309-12. doi: 10.1097/00043426-199707000-00008. J Pediatr Hematol Oncol. 1997. PMID: 9256829 Clinical Trial.

4

Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.

Rackoff WR, Orazi A, Robinson CA, Cooper RJ, Alter BP, Freedman MH, Harris RE, Williams DA. Rackoff WR, et al. Blood. 1996 Sep 1;88(5):1588-93. Blood. 1996. PMID: 8781414 Free article. Clinical Trial.

5

A case-control retrospective study of the efficacy of granulocyte-colony-stimulating factor in children with neuroblastoma.

Housholder SE, Rackoff WR, Goldman J, Breitfeld PP. Housholder SE, et al. Among authors: rackoff wr. Am J Pediatr Hematol Oncol. 1994 May;16(2):132-7. Am J Pediatr Hematol Oncol. 1994. PMID: 7513135

6

Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone.

Rackoff WR, Manno CS. Rackoff WR, et al. Am J Pediatr Hematol Oncol. 1994 May;16(2):156-9. Am J Pediatr Hematol Oncol. 1994. PMID: 8166369

7

Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Rackoff WR, Ge J, Sather HN, Cooper HA, Hutchinson RJ, Lange BJ. Rackoff WR, et al. J Pediatr Hematol Oncol. 1999 Jul-Aug;21(4):260-7. doi: 10.1097/00043426-199907000-00005. J Pediatr Hematol Oncol. 1999. PMID: 10445887

8

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.

Orlowski RZ, Nagler A, Sonneveld P, Bladé J, Hajek R, Spencer A, San Miguel J, Robak T, Dmoszynska A, Horvath N, Spicka I, Sutherland HJ, Suvorov AN, Zhuang SH, Parekh T, Xiu L, Yuan Z, Rackoff W, Harousseau JL. Orlowski RZ, et al. J Clin Oncol. 2007 Sep 1;25(25):3892-901. doi: 10.1200/JCO.2006.10.5460. Epub 2007 Aug 6. J Clin Oncol. 2007. PMID: 17679727 Clinical Trial.

9

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR. Razzouk BI, et al. Among authors: rackoff wr. J Clin Oncol. 2006 Aug 1;24(22):3583-9. doi: 10.1200/JCO.2005.03.4371. J Clin Oncol. 2006. PMID: 16877725 Clinical Trial.

10

A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children.

Rackoff WR, Weiman M, Jakobowski D, Hirschl R, Stallings V, Bilodeau J, Danz P, Bell L, Lange B. Rackoff WR, et al. J Pediatr. 1995 Jul;127(1):147-51. doi: 10.1016/s0022-3476(95)70276-8. J Pediatr. 1995. PMID: 7608801 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters